The five nonprofit plans — Blue Cross Blue Shield of Massachusetts, Blue Cross Blue Shield of Michigan, Blue Shield of California, Highmark and Independence Blue Cross —are funding the initiative, which aims to provide insight on patient experience with drugs and treatments. The amount each plan has provided to Evio has not been made public.
Through the partnership, Evio will track drug performance across an array of patient types and preexisting conditions or diseases.
Ultimately, the collaboration aims to challenge high drug prices through outcome-based contracting. The push also aims to promote “affordability, outcomes, and experience for patients,” according to the announcement, with an emphasis on innovation tied to collected data.
The startup is helmed by President and CEO Hank Schlissberg, a former executive at DaVita, who aims to cut down on price inflation between a drug’s manufacturer and the pharmacy counter through results-based contracts, he said in the announcement.
Latest articles on payer issues:
Centene’s East Coast headquarters: 6 updates
Aetna launches provider network focused on suicide prevention
Cigna offers telepsychiatry platform to behavioral health customers
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.